[Chine] China’s Sinovac says Covid-19 vaccine has high efficacy after lower Brazil figure

Auteurs : Zhuang Pinghui et Josephine Ma, journaliste du journal South China Morning Post

Production : South China Morning Post, quotidien de langue anglaise publié à Hong Kong depuis 1903. Sa diffusion s’élève à 104 000 exemplaires. Il est publié par le groupe SCMP, propriété de du groupe Alibaba depuis 2015.

Diffusion : site du journal South China Morning Post

Date et Heure : 13 janvier 2021, 17:37

– Brazilian partner earlier said CoronaVac was 50 per cent effective, but Sinovac moves to clarify the data

– Company will double production capacity in February to meet overseas and domestic demand, chairman says

Source : Zhuang Pinghui et Josephine Ma, “China’s Sinovac says Covid-19 vaccine has high efficacy after lower Brazil figure”, South China Morning Post, 13/01/2021. URL : https://www.scmp.com/news/china/article/3117588/chinas-sinovac-says-covid-19-vaccine-has-high-efficacy-after-lower (consulté le 13/01/2021).

Voir également :

Eduardo Baptista, “Coronavirus: Brazil finds China’s Sinovac vaccine to be less effective than previous data shows”, South China Morning Post, 13/01/2021. URL : https://www.scmp.com/news/china/science/article/3117471/coronavirus-brazil-reports-more-modest-504-cent-efficacy-chinas (consulté le 13/01/2021).

Josephine Ma , Zhuang Pinghui and Ji Siqi, “What do the Sinovac coronavirus vaccine efficacy results mean?”, South China Morning Post, 15/01/2021. URL : https://www.scmp.com/news/china/science/article/3117807/what-do-sinovac-coronavirus-vaccine-efficacy-results-mean (consulté le 15/01/2021).

Photo “à la une” : An employee inspects vials containing CoronaVac at Butantan’s centre in Sao Paulo. © Reuters

---

---